JPS6154398B2 - - Google Patents
Info
- Publication number
- JPS6154398B2 JPS6154398B2 JP53014549A JP1454978A JPS6154398B2 JP S6154398 B2 JPS6154398 B2 JP S6154398B2 JP 53014549 A JP53014549 A JP 53014549A JP 1454978 A JP1454978 A JP 1454978A JP S6154398 B2 JPS6154398 B2 JP S6154398B2
- Authority
- JP
- Japan
- Prior art keywords
- heparin
- heparitinase
- agarose
- solution
- immobilized
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 108010083213 heparitinsulfate lyase Proteins 0.000 claims description 55
- 229920000669 heparin Polymers 0.000 claims description 42
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 claims description 41
- 229960002897 heparin Drugs 0.000 claims description 41
- 229920000936 Agarose Polymers 0.000 claims description 36
- 238000004440 column chromatography Methods 0.000 claims description 8
- 239000000284 extract Substances 0.000 claims description 8
- 229910052588 hydroxylapatite Inorganic materials 0.000 claims description 8
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 claims description 8
- 238000004519 manufacturing process Methods 0.000 claims description 7
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims description 6
- 102000007327 Protamines Human genes 0.000 claims description 5
- 108010007568 Protamines Proteins 0.000 claims description 5
- 241000589565 Flavobacterium Species 0.000 claims description 4
- 239000003795 chemical substances by application Substances 0.000 claims description 4
- 229940048914 protamine Drugs 0.000 claims description 3
- 230000000813 microbial effect Effects 0.000 claims 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 18
- 239000000243 solution Substances 0.000 description 18
- 210000004027 cell Anatomy 0.000 description 13
- 230000001580 bacterial effect Effects 0.000 description 12
- 238000002360 preparation method Methods 0.000 description 12
- 102000004190 Enzymes Human genes 0.000 description 11
- 108090000790 Enzymes Proteins 0.000 description 11
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 10
- 238000000034 method Methods 0.000 description 10
- 238000000746 purification Methods 0.000 description 10
- 239000000872 buffer Substances 0.000 description 9
- 230000000694 effects Effects 0.000 description 9
- 230000001965 increasing effect Effects 0.000 description 9
- 239000011780 sodium chloride Substances 0.000 description 9
- 238000010828 elution Methods 0.000 description 7
- 230000000052 comparative effect Effects 0.000 description 6
- 101710106625 Chondroitinase-AC Proteins 0.000 description 5
- 108010048429 chondroitinase B Proteins 0.000 description 5
- 239000002609 medium Substances 0.000 description 5
- 239000008363 phosphate buffer Substances 0.000 description 5
- 241000605114 Pedobacter heparinus Species 0.000 description 4
- 229920002684 Sepharose Polymers 0.000 description 4
- 230000002378 acidificating effect Effects 0.000 description 4
- 239000007853 buffer solution Substances 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 238000011084 recovery Methods 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 238000007796 conventional method Methods 0.000 description 3
- AVJBPWGFOQAPRH-FWMKGIEWSA-L dermatan sulfate Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@H](OS([O-])(=O)=O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](C([O-])=O)O1 AVJBPWGFOQAPRH-FWMKGIEWSA-L 0.000 description 3
- 125000000524 functional group Chemical group 0.000 description 3
- 230000003100 immobilizing effect Effects 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- LMDZBCPBFSXMTL-UHFFFAOYSA-N 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide Chemical compound CCN=C=NCCCN(C)C LMDZBCPBFSXMTL-UHFFFAOYSA-N 0.000 description 2
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 229920001287 Chondroitin sulfate Polymers 0.000 description 2
- 229920002683 Glycosaminoglycan Polymers 0.000 description 2
- 108010022901 Heparin Lyase Proteins 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 229940059329 chondroitin sulfate Drugs 0.000 description 2
- ATDGTVJJHBUTRL-UHFFFAOYSA-N cyanogen bromide Chemical compound BrC#N ATDGTVJJHBUTRL-UHFFFAOYSA-N 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 238000005194 fractionation Methods 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 229950008679 protamine sulfate Drugs 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- -1 For example Polymers 0.000 description 1
- 108010023736 Chondroitinases and Chondroitin Lyases Proteins 0.000 description 1
- 102000011413 Chondroitinases and Chondroitin Lyases Human genes 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000008351 acetate buffer Substances 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- VSGNNIFQASZAOI-UHFFFAOYSA-L calcium acetate Chemical compound [Ca+2].CC([O-])=O.CC([O-])=O VSGNNIFQASZAOI-UHFFFAOYSA-L 0.000 description 1
- 239000001639 calcium acetate Substances 0.000 description 1
- 229960005147 calcium acetate Drugs 0.000 description 1
- 235000011092 calcium acetate Nutrition 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 150000001718 carbodiimides Chemical class 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 230000019522 cellular metabolic process Effects 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 125000003700 epoxy group Chemical group 0.000 description 1
- 238000002523 gelfiltration Methods 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- ZFGMDIBRIDKWMY-PASTXAENSA-N heparin Chemical compound CC(O)=N[C@@H]1[C@@H](O)[C@H](O)[C@@H](COS(O)(=O)=O)O[C@@H]1O[C@@H]1[C@@H](C(O)=O)O[C@@H](O[C@H]2[C@@H]([C@@H](OS(O)(=O)=O)[C@@H](O[C@@H]3[C@@H](OC(O)[C@H](OS(O)(=O)=O)[C@H]3O)C(O)=O)O[C@@H]2O)CS(O)(=O)=O)[C@H](O)[C@H]1O ZFGMDIBRIDKWMY-PASTXAENSA-N 0.000 description 1
- 229960001008 heparin sodium Drugs 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 230000008288 physiological mechanism Effects 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000002525 ultrasonication Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
Landscapes
- Enzymes And Modification Thereof (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP1454978A JPS54107585A (en) | 1978-02-10 | 1978-02-10 | Preparation of pure heparitinase |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP1454978A JPS54107585A (en) | 1978-02-10 | 1978-02-10 | Preparation of pure heparitinase |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS54107585A JPS54107585A (en) | 1979-08-23 |
| JPS6154398B2 true JPS6154398B2 (enrdf_load_stackoverflow) | 1986-11-21 |
Family
ID=11864224
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP1454978A Granted JPS54107585A (en) | 1978-02-10 | 1978-02-10 | Preparation of pure heparitinase |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS54107585A (enrdf_load_stackoverflow) |
-
1978
- 1978-02-10 JP JP1454978A patent/JPS54107585A/ja active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPS54107585A (en) | 1979-08-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Danishefsky et al. | Synthesis of heparin-sepharoses and their binding with thrombin and antithrombin-heparin cofactor | |
| DK173385B1 (da) | Analogifremgangsmåde til fremstilling af oligosaccharidfraktioner eller oligosaccharider med specifik anti-Xa-aktivitet | |
| JPS63118301A (ja) | リガンド結合多糖類 | |
| EP0140386B1 (en) | Method for the purification of lpf-ha | |
| JPS6154398B2 (enrdf_load_stackoverflow) | ||
| JPS6111593B2 (enrdf_load_stackoverflow) | ||
| JPS6031478B2 (ja) | 純コンドロイチナ−ゼｂの製造法 | |
| JPS6154451A (ja) | 群特異性を有するアフイニテイクロマトグラフイ用ゲルおよびその製法 | |
| JPS6031479B2 (ja) | 純コンドロイチナ−ゼｃの製造法 | |
| SU1419717A1 (ru) | Способ получени биоспецифических адсорбентов дл выделени фибронектина и коллагеназ | |
| US4729957A (en) | Process for manufacture of L-asparaginase from erwinia chrysanthemi | |
| JPH0147997B2 (enrdf_load_stackoverflow) | ||
| EP0263484B1 (en) | Method for isolation and purification of amylases, and adsorbents used for the same as well as devices for the isolation and purification | |
| EP0059182B1 (en) | A process for isolating aminoacylase enzyme from a mammal kidney extract | |
| GB2024228A (en) | Process and adsorbent for the isolation in purer form of enzyme(s) from a crude enzyme solution | |
| Schöpp et al. | Specific hydrophobic chromatography of alcohol dehydrogenases on 10-carboxydecyl-sepharose | |
| JPH0556952B2 (enrdf_load_stackoverflow) | ||
| JPS589686A (ja) | ス−パ−オキサイドジスムタ−ゼの精製法 | |
| RU2248801C2 (ru) | Способ получения низкомолекулярных гепаринов | |
| JPS6120268B2 (enrdf_load_stackoverflow) | ||
| Krishnapillai et al. | Extraction and purification of hyaluronoglucosidase (EC 3.2. 1.35) from Norway lobster (Nephrops norvegicus) | |
| WO1987003618A1 (en) | Process for manufacture of l-asparaginase from erwinia carotovora | |
| SU668348A1 (ru) | Способ выделени -амилазы | |
| JPH0665406A (ja) | 酸性多糖を結合させた陰イオン交換樹脂 | |
| JPS62262991A (ja) | ３−オキソ−５β−ステロイド−Δ↑４−デヒドロゲナ−ゼの単離精製法 |